Life Tech and RainDance to Co-Market Microdroplet PCR for Targeted Sequencing on SOLiD | GenomeWeb

RainDance Technologies and Life Technologies' Applied Biosystems unit have penned a strategic co-marketing agreement, the companies said last week.

Under the agreement, the firms will co-market RainDance's RDT 1000 sequence enrichment solution, which is based on microdroplet PCR, with ABI's SOLiD system.

In addition, the companies will continue to collaborate to use RainDance products in the SOLiD sequencing workflow.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.